Publication Cover
Redox Report
Communications in Free Radical Research
Volume 15, 2010 - Issue 1
836
Views
26
CrossRef citations to date
0
Altmetric
Research articles

Bioavailability and catalytic properties of copper and iron for Fenton chemistry in human cerebrospinal fluid

Pages 29-35 | Published online: 19 Jul 2013

References

  • Smith MA, Harris PLR, Sayre LM, Perry G. Iron accumulation in Alzheimer disease is a source of redox generated free radicals. Proc Nat! Acad Sci USA 1997; 94: 9866–9868.
  • Koppenol WH. Fenton chemistry and iron chelation under physiologically relevant conditions: electrochemistry and kinetics. Chem Res Toxicol 2006; 19: 1263–1269.
  • Cui K, Luo X, Xu K, Murthy MRV. Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28: 771–799.
  • Boll MC, Alcaraz-Zubeldia M, Montes S, Rios C. Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NOx content in the CSF. A different marker profile in four neurodegenerative diseases. Neurochem Res 2008; 33: 1717–1723.
  • Liu D, Wen J, Liu J, Li L. The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids. FASEB J 1999; 13: 2318–2328.
  • Huang X, Atwood CS, Hartshorn MA et al. The A13 peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 1999; 38: 7609–7616.
  • Takahashi S, Takahashi I, Sato H, Kubota Y, Yoshida S, Muramatsu Y Age-related changes in the concentrations of major and trace elements in the brain of rats and mice. Biol Trace Elem Res 2001; 80: 145–158.
  • Valko M, Morris H, Cronin MTD. Metals, toxicity and oxidative stress. Curr Med Chem 2005; 12: 1161–1208.
  • Barnham KJ, Masters CL, Bush AT. Neurodegenerative diseases and oxidative stress. Nat Rev 2004; 3: 205–214.
  • Cookson MR, Shaw PJ. Oxidative stress and motor neurone disease. Brain Pathol1999; 9: 165-186.
  • Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 1984; 120: 885–890.
  • Nakamura M, Shishido N, Nunomura A et al. Three histidine residues of amyloid-13 peptide control the redox activity of copper andiron. Biochemistry 2007; 46: 12737–12743.
  • Shapira AHV, Mann VM, Cooper JM, Krige D, Jenner PJ, Marsden CD. Mitochondrial function in Parkinson's disease. Ann Neurol 1992; 32: S116–S124.
  • Hirsch E, Graybiel AM, Agid YA. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature 1988; 334: 345–348.
  • Wakamatsu K, Fujikawa K, Zucca FA, Zecca L, Ito S. The structure of neuromelanin as studied by chemical degradative methods. J Neurochem 2003; 86: 1015–1023.
  • Gerard C, Chehhal H, Hugel RP. Complexes of iron(III) with ligands of biological interest: dopamine and 8-hydroxyquinoline-5-sulfonic acid. Polyhedron 1994; 13: 591–597.
  • Opazo C, Huang X, Chemy RA et al. Metalloenzyme-like activity of Alzheimer's disease 13-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H202. J Biol Chem 2002; 277: 40302–40308.
  • Oba H, Araki T, Ohtomo K et al. Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology 1993; 189: 843–846.
  • Ihara Y, Nobukuni K, Takata H, Hayabara T. Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu,Zn-superoxide dismutase mutation. Neurol Res 2005; 27: 105–108.
  • Sedlak DL, Hoigne J. The role of copper and oxalate in the redox cycling of iron in atmospheric waters. Atmos Environ 1993; 27: 2173–2185.
  • Buettner GR, Jurkiewicz BA. Catalytic metals, ascorbate and free radicals: combinations to avoid. Radic Res 1996; 145: 532–541.
  • Bacic G, Spasojevic I, Secerov B, Mojovic M. Spin-trapping of oxygen free radicals in chemical and biological systems: new traps, radicals and possibilities. Spectrochim Acta A 2008; 69: 1354–1366.
  • Teixeira MC, Telo JP, Duarte NF, Sá-Correiaa I. The herbicide 2,4-dichlorophenoxyacetic acid induces the generation of free-radicals and associated oxidative stress responses in yeast. Biochem Biophys Res Commun 2004; 324: 1101–1107.
  • Lentner C. Geigy Scientific Tables, vol 1, 8th edn. Basel: Ciba-Geigy, 1981.
  • Barb WG, Baxendale JH, George P, Hargrave KR. Reactions of ferrous and ferric ions with hydrogen peroxide. Part 1. - The ferrous ion reaction. Trans Farad Soc 1951; 47: 462–500.
  • Gutteridge JMC, Wilkins S. Copper salt-dependent hydroxyl radical formation damage to proteins acting as antioxidants. Biochim Biophys Acta 1983; 759: 38–41.
  • Yamamoto K, Kawanishi S. Hydroxyl free radical is not the main active species in site-specific DNA damage induced by copper (II) ion and hydrogen peroxide. J Biol Chem 1989; 264: 15435–15440.
  • Rae TD, Schmidt PJ, Pufahl RA, Culotta VC, O'Halloran TV. Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science 1999; 284: 805–808.
  • Graf E, Mahoney JR, Bryant RG, Eaton JW. Iron-catalyzed hydroxyl radical formation: stringent requirement for free iron coordination site. J Biol Chem 1984; 259: 3620–3624.
  • Michelson AM, Maral J. Carbonate anions; effects on the oxidation of luminal, oxidative hemolysis, y-irradiation and the reaction of activated oxygen species with enzymes containing various active centres. Biochimie 1983; 65: 95–104.
  • Engelmann MD, Bobier RT, Hiatt T, Cheng IF. Variability of the Fenton reaction characteristics of the EDTA, DTPA, and citrate complexes of iron. Biometals 2003; 16: 519–527.
  • Fong KL, McCay PB, Poyer JL. Evidence for superoxide dependent reduction of Fe3* and its role in enzyme generated hydroxyl radical formation. Chem Biol Interact 1976; 15: 77–89.
  • Nikolic-Kokic A, Stevie Z, Stojanovic S et al. Biotransformation of nitric oxide in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Redox Rep 2005; 10: 265–270.
  • Taqui Khan MM, Martell AE. Metal ion and metal chelate catalyzed oxidation of ascorbic acid by molecular oxygen. I Cupric and ferric ion catalyzed oxidation. J Am Chem Soc 1967; 89: 4176–4185.
  • Ghosh SK, Gould ES. Electron transfer. 98. Copper(II) and vanadium(IV) catalysis of the reduction of peroxide-bound chromium(IV) with ascorbic acid. Inorg Chem 1989; 28: 1948–1951.
  • Merkofer M, Kissner R, Hider R, Brunk UT, Koppenol WH. Fenton chemistry and iron chelation under physiologically relevant conditions: electrochemistry and kinetics. Chem Res Toxicol 2006; 19: 1263–1269.
  • Orescanin-Dusic Z, Milovanovic S, Nikolic-Kokic A, Radojcic R, Spasojevic I, Spasic M. Diethyldithiocarbamate potentiates the effects of protamine sulphate in the isolated rat uterus. Redox Rep 2009; 14: 48–54.
  • Van Faassen E, Vanin AF. (eds) Radicals for life. The various forms of nitric oxide, 1st edn. Amsterdam: Elsevier, 2007.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.